Healthcare

At the time of writing this article, Argent BioPharma (ASX:RGT) was trading at AUD 0.034, up 21.43% during today’s trading session. Argent BioPharma is a clinical-stage biopharmaceutical company developing and commercialising treatments targeting neurological, inflammatory and immune-related conditions. Its portfolio includes CannEpil, CimetrA and …

At the time of writing this article, Alterity Therapeutics (ASX:ATH) was trading at AUD 0.395, up 6.76% during today’s trading session. Alterity Therapeutics is a clinical-stage biotechnology company focused on developing disease-modifying therapies for neurodegenerative disorders. Its lead program, ATH434, is being developed for …

At the time of writing this article, Alcidion Group (ASX:ALC) was trading at AUD 0.105, up 5.00% during today’s trading session. Alcidion is a healthcare technology company providing software designed to support clinical workflows, patient flow, virtual care and electronic patient records. FY26 included …

At the time of writing this article, LTR Pharma (ASX) was trading at AUD 0.515, up 4.04% during today’s trading session. LTR Pharma is a clinical-stage biopharmaceutical company focused on developing and commercialising intranasal therapies, with its principal programs targeting erectile dysfunction. Its 2026 …

At the time of writing this article, OncoSil Medical (ASX:OSL) was trading at AUD 0.805, up 10.27% during today’s trading session. The Australian medical device company is focused on interventional oncology and has developed a targeted internal radiation treatment designed for difficult-to-treat cancers. During …

At the time of writing this article, Neurizon Therapeutics (ASX:NUZ) was trading at AUD 0.089, up 5.95% during today’s trading session. Neurizon Therapeutics is an Australian clinical-stage biotechnology company developing therapies for neurodegenerative diseases. Its main development program centres on NUZ-001, also known as …

At the time of writing this article, Lumos Diagnostics Holdings (ASX:LDX) was trading at AUD 0.105, up 5.00% during today’s trading session. Lumos is an Australian-listed diagnostics company focused on developing,Manufacturingand commercialising point-of-care diagnostic technologies. Its operations include proprietary diagnostic products such as FebriDx …